Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Gamze Camlik, Besa Bilakaya, Yildiz Ozsoy & Ismail Tuncer Degim. (2023) A new approach for the treatment of Alzheimer’s disease: insulin-quantum dots. Journal of Microencapsulation 0:0, pages 1-9.
Read now
Read now
Meenakshee Shrivas, Dignesh Khunt, Meera Shrivas & Manju Misra. (2023) Studies on pomegranate seed oil enriched galantamine hydrobromide microemulsion: formulation, in vitro antioxidant and neuroprotective potential. Pharmaceutical Development and Technology 28:2, pages 153-163.
Read now
Read now
Ankit Parikh, Krishna Kathawala, Jintao Li, Chi Chen, Zhengnan Shan, Xia Cao, Yan-Jiang Wang, Sanjay Garg & Xin-Fu Zhou. (2018) Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer’s disease model. Drug Design, Development and Therapy 12, pages 2111-2128.
Read now
Read now
Luigi Battaglia, Pier Paolo Panciani, Elisabetta Muntoni, Maria Teresa Capucchio, Elena Biasibetti, Pasquale De Bonis, Silvia Mioletti, Marco Fontanella & Shankar Swaminathan. (2018) Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery. Expert Opinion on Drug Delivery 15:4, pages 369-378.
Read now
Read now
Marc Fakhoury. (2016) Drug delivery approaches for the treatment of glioblastoma multiforme. Artificial Cells, Nanomedicine, and Biotechnology 44:6, pages 1365-1373.
Read now
Read now
Bruno Fonseca-Santos, Maria Palmira Daflon Gremião & Marlus Chorilli. (2015) Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease. International Journal of Nanomedicine 10, pages 4981-5003.
Read now
Read now
Guilherme J. M. Garcia, Jeffry D. Schroeter & Julia S. Kimbell. (2015) Olfactory deposition of inhaled nanoparticles in humans. Inhalation Toxicology 27:8, pages 394-403.
Read now
Read now
Articles from other publishers (58)
Lucia Zakharova, Gulnara Gaynanova, Elmira Vasilieva, Leysan Vasileva, Rais Pavlov, Ruslan Kashapov, Konstantin Petrov & Oleg Sinyashin. (2023) Recent Nanoscale Carriers for Therapy of Alzheimer's Disease:
Current Strategies and Perspectives. Current Medicinal Chemistry 30:33, pages 3743-3774.
Crossref
Crossref
Mathis Barbotin, Vincent Thoreau & Guylène Page. (2023) Brain tumours: Non-invasive techniques to treat invasive pathologies. Annales Pharmaceutiques Françaises.
Crossref
Crossref
Prativa Das, Jnyana Ranjan Panda, Ch Niranjan Patro, Baby Sahu & Soumya Stuti Patnaik. (2023) A Comprehensive Review of Nanoemulsion Applications and their Recent
Advancements. Current Nanomaterials 8:3, pages 209-223.
Crossref
Crossref
Zhiren Wang, Karina Marie Gonzalez, Leyla Estrella Cordova & Jianqin Lu. (2023) Nanotechnology‐empowered therapeutics targeting neurodegenerative diseases. WIREs Nanomedicine and Nanobiotechnology.
Crossref
Crossref
Thelma Akanchise & Angelina Angelova. (2023) Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy. Pharmaceutics 15:5, pages 1562.
Crossref
Crossref
Varunesh Sanjay Tambe & Sarika Wairkar. (2023) Lipid-based Nanocarriers via Nose-to-Brain Pathway for Alzheimer's and
Parkinson's Disease. Current Nanoscience 19:3, pages 322-337.
Crossref
Crossref
Ikram HasanBing Guo, Jian ZhangChunqi Chang. (2023) Advances in Antioxidant Nanomedicines for Imaging and Therapy of Alzheimer's Disease. Antioxidants & Redox Signaling.
Crossref
Crossref
Shiv Bahadur & Kamla Pathak. 2023. Nasal Drug Delivery. Nasal Drug Delivery
59
82
.
Waleed Bashir & Sana Shahzadi. (2022) Nanoparticles – a novel theranostic approach to treat alzheimer’s disease. Journal of Applied Biotechnology & Bioengineering 9:6, pages 216-220.
Crossref
Crossref
Yanyan Cao & Run Zhang. (2022) The application of nanotechnology in treatment of Alzheimer’s disease. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Gopikrishna Agraharam, Nishakavya Saravanan, Agnishwar Girigoswami & Koyeli Girigoswami. (2022) Future of Alzheimer’s Disease: Nanotechnology-Based Diagnostics and Therapeutic Approach. BioNanoScience 12:3, pages 1002-1017.
Crossref
Crossref
Heba A. Gad, Mai Mansour, Haidy Abbas, Rania T. Malatani, Mohamed A. Khattab & Enas Elmowafy. (2022) “Plurol will not miss the boat”: A new manifesto of galantamine conveyance. Journal of Drug Delivery Science and Technology 74, pages 103516.
Crossref
Crossref
Darshana Patel & Hetal Thakkar. (2022) Formulation considerations for improving intranasal delivery of CNS acting therapeutics. Therapeutic Delivery 13:7, pages 371-381.
Crossref
Crossref
Abdul Waris, Asmat Ali, Atta Ullah Khan, Muhammad Asim, Doaa Zamel, Kinza Fatima, Abdur Raziq, Muhammad Ajmal Khan, Nazia Akbar, Abdul Baset & Mohammed A. S. Abourehab. (2022) Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders. Nanomaterials 12:13, pages 2140.
Crossref
Crossref
Mohammad Yaghoub Abdollahzadeh Jamalabadi & Jinxiang Xi. (2022) Olfactory Drug Aerosol Delivery with Acoustic Radiation. Biomedicines 10:6, pages 1347.
Crossref
Crossref
Elisabetta Muntoni, Elisabetta Marini, Chiara Ferraris, Sara Garelli, Maria Teresa Capucchio, Elena Colombino, Pier Paolo Panciani & Luigi Battaglia. (2022) Intranasal lipid nanocarriers: Uptake studies with fluorescently labeled formulations. Colloids and Surfaces B: Biointerfaces 214, pages 112470.
Crossref
Crossref
Cándida A. Cisneros-Covarrubias, César F.A. Gómez-Durán, Patricia Aguirre-Bañuelos, Rosa Alejandra Hernández-Esquivel & Gabriela Palestino. (2022) Tramadol extended-release porous silicon microcarriers: A kinetic, physicochemical and biological evaluation. Journal of Drug Delivery Science and Technology 69, pages 103132.
Crossref
Crossref
Davood Gheidari & Mohammad Bayat. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases
17
39
.
Pallav Namdeo, Jinu Mathew & Ashish Garg. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases
223
242
.
Elena Boldyreva. (2021) Glycine: The Gift that Keeps on Giving. Israel Journal of Chemistry 61:11-12, pages 828-850.
Crossref
Crossref
Fong LaiGuan Zoey, Mathangi Palanivel, Parasuraman Padmanabhan & Balázs Gulyás. (2021) Parkinson’s Disease: A Nanotheranostic Approach Targeting Alpha-Synuclein Aggregation. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Ze Qiang Zhao, Bo Zhi Chen, Xiao Peng Zhang, Hui Zheng & Xin Dong Guo. (2021) An Update on the Routes for the Delivery of Donepezil. Molecular Pharmaceutics 18:7, pages 2482-2494.
Crossref
Crossref
Nazeer Hussain Khan, Maria Mir, Ebenezeri Erasto Ngowi, Ujala Zafar, Muhammad Mahtab Aslam Khan Khakwani, Saadullah Khattak, Yuan-Kun Zhai, En-She Jiang, Meng Zheng, Shao-Feng Duan, Jian-She Wei, Dong-Dong Wu & Xin-Ying Ji. (2021) Nanomedicine: A Promising Way to Manage Alzheimer’s Disease. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Crossref
Manisha Choudhari, Siddhanth Hejmady, Ranendra Narayan Saha, Shantanu Damle, Gautam Singhvi, Amit Alexander, Prashant Kesharwani & Sunil Kumar Dubey. (2021) Evolving new-age strategies to transport therapeutics across the blood-brain-barrier. International Journal of Pharmaceutics 599, pages 120351.
Crossref
Crossref
Leonor C. Fonseca, João A. Lopes, João Vieira, Cláudia Viegas, Cláudia S. Oliveira, Rafael P. Hartmann & Pedro Fonte. (2021) Intranasal drug delivery for treatment of Alzheimer’s disease. Drug Delivery and Translational Research 11:2, pages 411-425.
Crossref
Crossref
Angela Bonaccorso, Rosalia Pellitteri, Barbara Ruozi, Carmelo Puglia, Debora Santonocito, Rosario Pignatello & Teresa Musumeci. (2021) Curcumin Loaded Polymeric vs. Lipid Nanoparticles: Antioxidant Effect on Normal and Hypoxic Olfactory Ensheathing Cells. Nanomaterials 11:1, pages 159.
Crossref
Crossref
Mukta Agrawal, Aditya Narayan Konwar, Amit Alexander & Vivek Borse. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
305
328
.
Chandrakantsing V. Pardeshi & Eliana B. Souto. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
93
114
.
Rajesh Kumar, Monica Gulati, Sachin Kumar Singh, Deepika Sharma & Omji Porwal. (2020) Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps. CNS & Neurological Disorders - Drug Targets 19:9, pages 663-675.
Crossref
Crossref
Mugdha Agarwal, Mohammad Rizwan Alam, Mohd Kabir Haider, Md. Zubbair Malik & Dae-Kwang Kim. (2020) Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology. Nanomaterials 11:1, pages 59.
Crossref
Crossref
Shiv Bahadur, Dinesh M. Pardhi, Jarkko Rautio, Jessica M. Rosenholm & Kamla Pathak. (2020) Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders. Pharmaceutics 12:12, pages 1230.
Crossref
Crossref
Parasuraman Padmanabhan, Mathangi Palanivel, Ajay Kumar, Domokos Máthé, George K. RaddaKah-Leong Lim & Balázs Gulyás. (2020) Nanotheranostic agents for neurodegenerative diseases. Emerging Topics in Life Sciences 4:6, pages 645-675.
Crossref
Crossref
Sofia Toniolo, Arjune Sen & Masud Husain. (2020) Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease. International Journal of Molecular Sciences 21:23, pages 9318.
Crossref
Crossref
Jinqiu Ma, Chenyun Wang, Yunbo Sun, Lulu Pang, Siqing Zhu, Yijing Liu, Lin Zhu, Shouguo Zhang, Lin Wang & Lina Du. (2020) Comparative study of oral and intranasal puerarin for prevention of brain injury induced by acute high-altitude hypoxia. International Journal of Pharmaceutics 591, pages 120002.
Crossref
Crossref
Mukta Agrawal, Shailendra Saraf, Swarnlata Saraf, Sunil K. Dubey, Anu Puri, Umesh Gupta, Prashant Kesharwani, V. Ravichandiran, Pramod Kumar, V.G.M. Naidu, Upadhyayula Suryanarayana Murty, Ajazuddin & Amit Alexander. (2020) Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. Journal of Controlled Release 327, pages 235-265.
Crossref
Crossref
Samane Heydari, Mojtaba Hedayati Ch, Farshid Saadat, Mahmood Abedinzade, Iraj Nikokar, Ehsan Aboutaleb, Abolfazl Khafri & Ali Rezaei Mokarram. (2019) Diphtheria toxoid nanoparticles improve learning and memory impairment in animal model of Alzheimer’s disease. Pharmacological Reports 72:4, pages 814-826.
Crossref
Crossref
Shiv Bahadur, Nidhi Sachan, Ranjit K. Harwansh & Rohitas Deshmukh. (2020) Nanoparticlized System: Promising Approach for the Management of Alzheimer’s Disease through Intranasal Delivery. Current Pharmaceutical Design 26:12, pages 1331-1344.
Crossref
Crossref
Ramin Ansari, Seyed Mahdi Sadati, Negin Mozafari, Hajar Ashrafi & Amir Azadi. (2020) Carbohydrate polymer-based nanoparticle application in drug delivery for CNS-related disorders. European Polymer Journal 128, pages 109607.
Crossref
Crossref
Wenyuan Chen, Ruiteng Li, Siqing Zhu, Jinqiu Ma, Lulu Pang, Baiping Ma, Lina Du & Yiguang Jin. (2020) Nasal timosaponin BII dually sensitive in situ hydrogels for the prevention of Alzheimer’s disease induced by lipopolysaccharides. International Journal of Pharmaceutics 578, pages 119115.
Crossref
Crossref
Flávia Nathiely Silveira Fachel, Morgana Dal Prá, Juliana Hofstätter Azambuja, Marcelo Endres, Valquíria Linck Bassani, Letícia Scherer Koester, Amelia Teresinha Henriques, Alethea Gatto Barschak, Helder Ferreira Teixeira & Elizandra Braganhol. (2019) Glioprotective Effect of Chitosan-Coated Rosmarinic Acid Nanoemulsions Against Lipopolysaccharide-Induced Inflammation and Oxidative Stress in Rat Astrocyte Primary Cultures. Cellular and Molecular Neurobiology 40:1, pages 123-139.
Crossref
Crossref
Safura Jokar, Saeedeh Khazaei, Hossein Behnammanesh, Amir Shamloo, Mostafa Erfani, Davood Beiki & Omid Bavi. (2019) Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer’s disease therapy. Biophysical Reviews 11:6, pages 901-925.
Crossref
Crossref
Iren Yeeling Wu, Trygg Einar Nikolaisen, Nataša Škalko-Basnet & Massimiliano Pio di Cagno. (2019) The Hypotonic Environmental Changes Affect Liposomal Formulations for Nose-to-Brain Targeted Drug Delivery. Journal of Pharmaceutical Sciences 108:8, pages 2570-2579.
Crossref
Crossref
Wei Tang, Wenpei Fan, Joseph Lau, Liming Deng, Zheyu Shen & Xiaoyuan Chen. (2019) Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics. Chemical Society Reviews 48:11, pages 2967-3014.
Crossref
Crossref
Zuo-Wei Li, Xiao-Nan Zheng & Ping Li. (2019) Time-effect relationship of acupuncture on histopathology, ultrastructure, and neuroethology in the acute phase of cerebral hemorrhage. Neural Regeneration Research 14:1, pages 107.
Crossref
Crossref
Flávia Nathiely Silveira Fachel, Roselena Silvestri Schuh, Kleyton Santos Veras, Valquíria Linck Bassani, Letícia Scherer Koester, Amelia Teresinha Henriques, Elizandra Braganhol & Helder Ferreira Teixeira. (2019) An overview of the neuroprotective potential of rosmarinic acid and its association with nanotechnology-based delivery systems: A novel approach to treating neurodegenerative disorders. Neurochemistry International 122, pages 47-58.
Crossref
Crossref
Magisetty Obulesu. 2019. Alzheimer's Disease Theranostics. Alzheimer's Disease Theranostics
45
50
.
Kristin Huntoon, Russell R. Lonser & James B. Elder. 2019. Nervous System Drug Delivery. Nervous System Drug Delivery
379
403
.
Xinxin Wang & Fangxia Guan. 2019. Therapeutic Intranasal Delivery for Stroke and Neurological Disorders. Therapeutic Intranasal Delivery for Stroke and Neurological Disorders
117
133
.
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, Sophia G. Antimisiaris, Mahavir Bhupal Chougule, Sunday A. Shoyele & Amit Alexander. (2018) Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs. Journal of Controlled Release 281, pages 139-177.
Crossref
Crossref
Adeola Shobo, Annapurna Pamreddy, Hendrik G Kruger, Maya M Makatini, Tricia Naicker, Thavendran Govender & Sooraj Baijnath. (2018) Enhanced brain penetration of pretomanid by intranasal administration of an oil-in-water nanoemulsion. Nanomedicine 13:9, pages 997-1008.
Crossref
Crossref
Fabio Sonvico, Adryana Clementino, Francesca Buttini, Gaia Colombo, Silvia Pescina, Silvia Stanisçuaski Guterres, Adriana Raffin Pohlmann & Sara Nicoli. (2018) Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting. Pharmaceutics 10:1, pages 34.
Crossref
Crossref
Mrunali R. Patel, Rashmin B. Patel & Shivam D. Thakore. 2018. Applications of Nanocomposite Materials in Drug Delivery. Applications of Nanocomposite Materials in Drug Delivery
667
700
.
Ling Rong Wong & Paul C Ho. (2018) Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer's disease. Journal of Pharmacy and Pharmacology 70:1, pages 59-69.
Crossref
Crossref
Qizhi Zhang & Chi Zhang. 2017. Nanotechnology Methods for Neurological Diseases and Brain Tumors. Nanotechnology Methods for Neurological Diseases and Brain Tumors
227
239
.
Rizwanul Haque & Aamir Nazir. 2017. Drug Design: Principles and Applications. Drug Design: Principles and Applications
9
29
.
Rashmin B. Patel, Shivam D. Thakore & Mrunali R. Patel. 2017. Nanotechnology Applied To Pharmaceutical Technology. Nanotechnology Applied To Pharmaceutical Technology
335
359
.
Yan-hua Li, Ling Feng, Guang-Xian Zhang & Cun-gen Ma. (2015) Intranasal delivery of stem cells as therapy for central nervous system disease. Experimental and Molecular Pathology 98:2, pages 145-151.
Crossref
Crossref
Ti-Fei Yuan, Yu-Xiang Liang & Kwok-Fai So. (2015) Occurrence of new neurons in the piriform cortex. Frontiers in Neuroanatomy 8.
Crossref
Crossref